Feedback / Questions
BFI-751 (ustekinumab biosimilar) - BioFactura
https://www.einnews.com/pr_news/595437328/biofactura-s-biosimilar-ustekinumab-demonstrates-pharmacokinetic-pk-bioequivalence-to-stelara-in-phase-1-study
Oct 13, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next